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The Role of Minimally Invasive 
Surgery in the Treatment of Lung 
Cancer
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Abstract
Lobectomy plus regional lymph node dissection remains the gold standard 
treatment method in early-stage lung cancer. However, with the demonstration of 
the safety and efficacy of minimally invasive approaches, the expression of surgery 
in this statement, replaced by thoracoscopic anatomical lung resection. Clinical 
studies have demonstrated the superiority of VATS in terms of postoperative pain, 
drainage time, length of hospital stay, and complications, moreover, long-term 
oncologic results are similar or better than thoracotomy. Therefore, VATS lobec-
tomy is the preferred surgical method in early-stage lung cancer. Different surgical 
techniques are available in VATS and can be modified according to the surgeon’s 
personal experience. Uniport can be applied as well as two or three port incisions. 
In this book section, I plan to focus on VATS lobectomy, technique-related tricks, 
complication management, and long-term oncologic results in early and locally 
advanced lung cancer.
Keywords: Lobectomy, minimally invasive surgery, robotic surgery, video-assisted 
thoracic surgery
1. Introduction
Lung cancer is the most common cancer and the leading cause of cancer death 
in both genders [1]. Its high frequency and high mortality increase the importance 
of early diagnosis and treatment in this disease. Despite promising recent advances 
in diagnosis and treatment methods, only a minority of patients have a cure chance. 
Resection of the primary tumor and mediastinal lymph node dissection/sampling 
is the gold standard treatment method in this group of patients. However, in these 
patients, lung resection was performed by open thoracotomy until the end of the 
‘90s, regardless of the size of the tumor and the extent of cancer. Severe postopera-
tive pain and long hospitalization and drainage periods could prolong the recovery 
period of the patients [2].
Following the technological developments include high-definition video moni-
tors, robot-assisted technology, specialized thoracoscopic surgical instruments, and 
endomechanical stapling devices, the emergence of modern imaging systems and 
the use of appropriate surgical equipment has created the concept of “minimally 
invasive surgery”. In the early 2000s, patient series including Video-assisted thoracic 
surgery (VATS) applications began to be published. This and many subsequent 
studies have demonstrated the superiority of VATS over a thoracotomy in terms of less 
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postoperative pain and minimize complications hasten recovery and improve post-
operative quality [3–6]. With the positive results of VATS, it has found a wide applica-
tion area for the diagnosis and treatment of benign and malignant lung diseases.
In this section, the role and application areas of VATS in the diagnosis and 
treatment of lung cancer will be discussed rather than technical details.
2. Surgical technique
Although “tubeless” or “awake” VATS has been described and performed suc-
cessfully by several authors, single-lung ventilation, which may be accomplished 
with either double-lumen endobronchial tubes or with single-lumen tubes and 
bronchial blockers, is often required for thoracoscopic lobectomy [7, 8].
The patient is positioned in full lateral decubitus position with slight flexion 
of the table at the level of the mid-chest, which allows slight splaying of the ribs to 
improve exposure in the absence of rib spreading.
The instruments and surgical technique used vary according to the number, 
location, and width of the port incisions. Although the number of port incisions 
and locations are the surgeon’s preference, different applications and techniques 
have emerged over time.
2.1 Posterior approach
The posterior approach was first described by Walker WS in 1992. The main 
components of this approach include [6, 9]:
• The surgeon stands posterior to the patient.
• The utility incision is made at the 6th or 7th intercostal space anterior to latis-
simus dorsi muscle.
• The camera port is made through the auscultatory triangle, instead of the lower 
anterior axillary line;
• The aim is to dissect the hilar structures from the posterior to the anterior. For 
this purpose, the interlobar fissure must be opened first to identify and isolate 
pulmonary arterial branches.
The main advantages of the posterior approach include:
• Easy access to the posterior hilum.
• Easy access to subcarinal lymph nodes.
• A clear view of the posterior hilum allows safe dissection of the segmental 
artery and bronchial branches.
However, the interlobar fissure is incomplete in a considerable number of 
patients, and fissure dissection may cause parenchymal damage and prolonged air 
leak in the postoperative period. If the posterior approach is preferred, the interlo-
bar fissure should be carefully dissected. Tissue glues, absorbable patches, or fibrin 
sealants can be used in the repair of injuries and air leaks that may occur in the 
parenchyma.
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2.2 Anterior approach
The anterior approach, also known as the fissureless technique, was applied 
firstly in open thoracotomy in 1999. The application of this technique to VATS has 
been described recently [10–12]. In this technique, the surgeon stands anterior to 
the patient, and the camera port is placed at the anterior axillary line. The hilar 
structures are dissected from the anterior to the posterior. After the dissection of 
the bronchovascular structures is completed, the interlobar fissure is divided with 
endoscopic staplers and the lobe is removed from the thorax.
This approach aims to prevent postoperative air leaks due to fissure dissection.
2.3 3-port VATS
In this technique, the camera port-anterior port is located in the 7th or 8th 
intercostal space in the anterior axillary line, and the posterior port is located in 
the posterior axillary line in the same intercostal space. The utility port was usually 
placed in the anterior axillary line 4th intercostal space for an upper lobectomy or 
5th intercostal space for a lower lobectomy (Figure 1). While the posterior port was 
Figure 1. 
Port incisions in the 3-port VATS technique.
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previously placed from the upper and rear levels, it was modified over time, and the 
localization we described became more frequently applied [13].
2.4 2-port VATS
Since the additional contribution of the posterior port is not essential, VATS has 
become applied with two ports in some centers. The need for surgical retraction 
and manipulation can be provided by using another instrument via the utility port 
(Figure 2). However, apart from providing retraction, another feature of the poste-
rior port that makes it useful is the introduction of the endoscopic stapling devices. 
Therefore, the absence of the posterior port should be compensated by appropriate 
maneuver and retraction of the lung.
2.5 Uniportal VATS
Uniportal VATS is firstly described by Dr. Gaetano Rocco for minor thoracic 
procedures include lung biopsies and pneumothorax operations [14]. Dr. Diego 
Figure 2. 
Port incisions in the 2-port VATS technique.
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Gonzalez Rivas shared his single port VATS lobectomy experience and became a 
pioneer in this regard [15, 16]. It has become preferred by many surgeons due to its 
advantages, such as causing less tissue damage and providing direct vision.
3–5 cm uniport incision is placed in the 5th intercostal in the anterior axil-
lary line. A 5 mm diameter 30° video-thoracoscope is inserted through the same 
incision. Thus, the assistant and the surgeon share the same vision of direction. 
Although this is beneficial in terms of team cooperation, the working environment 
of the surgeon is somewhat limited.
Moreover, Gonzales Rivas successfully performed extended lung resections 
include bronchial, arterial, and double sleeve resections and raised the bar in uni-
portal VATS lobectomy [17]. Despite favorable surgical results, whether uniportal 
VATS has an additional benefit over traditional VATS is still controversial.
2.6 Needlescopic VATS
The main goal of this technique is to reduce the size of the incisions rather 
than the number of ports. It was aimed to minimize intercostal nerve damage and 
achieve better cosmetic results with the use of instruments and ports with a diam-
eter of 3–5 mm instead of 10 mm ones used in conventional VATS [18].
The placement of the ports and the direction of the vision are the same as the 
3-port VATS technique, and the utility port has to remain at 3–5 cm to extract the 
resection material. Surgeons who have appropriate instruments include 3 mm 
trocar, 3 mm 30° video-thoracoscope, and needlescopic grasper and do not prefer 
the uniportal VATS may prefer this technique.
2.7 Robot-assisted thoracic surgery
Advances in technology have enabled robots to be used in surgical procedures, 
and some authors started to share their first experiences in robotic thoracic surgery 
in the early 2000s [19].
It is thought that robotic surgery, which provides 3-dimensional vision and has 
articulated modern instruments, may allow the surgeon a safer dissection. With 
increasing experience, many thoracic surgery procedures are successfully per-
formed with robotic surgery [20].
However, its use has not become widespread worldwide due to the system’s 
higher cost, the time-consuming installation, and the lack of tactile feedback dur-
ing surgery. It is possible to achieve similar surgical results with much less expense 
without sacrificing minimal invasiveness.
3. Diagnostic performance of VATS in patients with lung cancer
Despite advances in imaging technology techniques, including positron emis-
sion tomography (PET), integrated PET/computed tomography (CT) scans, PET/
magnetic resonance imaging (MRI), multi-slice computed tomography, invasive 
diagnostic procedures continue to play an essential role in the management of the 
patient with lung cancer.
VATS provides the opportunity to evaluate for solitary pulmonary nodules, 
mediastinal or chest wall invasion by the primary tumor, pleural effusions/
nodules, and mediastinal lymph nodes. Especially in the recent period, the use of 
targeted treatment methods has increased the need for tissue for mutation analy-
sis. This situation has increased the diagnostic value of VATS and has widened its 
usage area.
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3.1 Mediastinal staging
Evaluate the mediastinal and hilar lymph node status is essential for accurate 
staging of the lung cancer and to choose the appropriate treatment modality.
Noninvasive mediastinal staging methods include CT and PET/CT provide valu-
able clinical information however sensitivity, specificity, and negative predictive 
values insufficient to guide treatment decisions [21–23].
Abnormal lymph node (LN) is described as an LN with a short-axis diam-
eter ≥ 1 cm). The median sensitivity and specificity of CT for identifying mediasti-
nal lymph node metastasis are 55% and 81% [21].
PET can provide more accurate information about the differentiation of malig-
nant and benign lymph nodes than CT. The median sensitivity and specificity of 
PET/CT for detecting lymph node metastases is ranges 80%- 88%, PET is success-
fully used in clinical staging and monitoring response to treatment in patients with 
lung cancer. However, the risk of false negativity is relatively high in lesions smaller 
than 1 cm and tumors with low metabolic activity (e.g. well-differentiated adeno-
carcinoma) [22, 23].
Cervical mediastinoscopy is the gold standard method for preoperative medias-
tinal lymph node staging in patients with lung cancer. The 2nd, 4th, and 7th station 
lymph nodes can be sampled by mediastinoscopy [24, 25]. Nowadays, cervical 
mediastinoscopy is performed with the help of a videomediastinoscope and it is 
named “video-assisted mediastinoscopy (VAM)” or “video-assisted mediastinal 
lymphadenectomy (VAMLA)” depending on the application technique [26].
Endobronchial ultrasound (EBUS) and endoscopic ultrasound (EUS), which are 
parts of minimally invasive procedures, are successfully applied with high sensitiv-
ity and specificity for mediastinal staging. Combined application of EBUS and EUS 
allows sampling of lymph node stations numbered 2R, 2 L, 4R, 4 L, 7, 8, and 9 with 
the sensitivity of 86% (95% CI, 82–90%) [21, 24, 27].
VATS is very useful in the evaluation of lymph nodes as well as the evalua-
tion of the T factor of the tumor. It allows for access to almost every mediastinal 
lymph node station and total mediastinal lymphadenectomy can be applied [28]. 
With the right-sided VATS, lymph node stations numbered 2,4,7,8 and 9 can 
be sampled (Figures 3 and 4). Left-sided VATS is an ideal approach for sam-
pling the 5th and 6th lymph node stations that cannot be reached by EBUS and 
mediastinoscopy.
Although the awake/tubeless VATS procedure has been described, general anes-
thesia and intubation with a double-lumen tube are usually required and it can only 
evaluate one side of the mediastinum. In conclusion, it is an approach that offers 
Figure 3. 
Intraoperative image of the lung parenchyma after the CT-guided methylene blue labeling.
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high specificity and sensitivity values, especially in patients who require sampling 
of 5th and 6th lymph node stations or in whom complete lymph node dissection is 
planned.
3.2 Investigation of the pulmonary nodules
With the widespread use of radiological imaging methods, patients with newly 
detected pulmonary nodules constitute an important part of daily practice.
According to the recommendations of the Fleischner Society, solitary pulmo-
nary nodules larger than 8 mm are recommended for further examination include 
tissue sampling regardless of cancer risk status [29]. CT-guided percutaneous 
transthoracic needle aspiration or transbronchial biopsy can be applied to pulmo-
nary nodules with appropriate location and size. However, regardless of the location 
or size of the pulmonary nodule, sufficient material cannot always be obtained for 
cytopathological examination by transthoracic and transbronchial biopsy.
VATS is a useful approach for pulmonary nodules that cannot be sampled with 
minor diagnostic procedures. However, probe or digital palpation is very difficult 
for ground-glass opacity (GGO) lesions and nodules smaller than 1 cm. To solve 
this problem several pre-operative and perioperative marking techniques were 
described in the literature:
• Preoperative CT-guided injection of methylene blue [30].
• CT-guided positioning of a metal wire [31].
• CT-guided placement of a micro coil [32].
• Pleural dye marking using electromagnetic navigation bronchoscopy with or 
without radial endobronchial ultrasound [33].
• Gamma probe assessment after marking with Technetium-99 [34].
• The intrathoracic stamping method [35].
Each of the methods listed above has advantages and disadvantages and it is 
controversial which is the best method for marking the pulmonary nodules. We 
use the “CT-guided injection of methylene blue” method for marking the pulmo-
nary nodules in our clinic (Figure 5). It is a simple, safe and effective procedure. 
Figure 4. 
VATS is also an effective method in the diagnosis and treatment of undiagnosed lesions located in the 
mediastinum. Para-aortic large mass resected and diagnosed as ectopic mediastinal thyroid.
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However, in order to ensure optimal labeling, the radiologist and the surgeon must 
be in good collaboration and the time between labeling and operation must be kept 
as short as possible.
4. The role of VATS in the surgical treatment of the lung cancer
Surgical resection in lung cancer has a relatively long history. First successful 
en bloc pneumonectomy reported by Graham and Singer in 1933 for the treatment 
of lung cancer. Lobectomies and segmentectomies were reported in the 1940s 
and 1950s and the first successful sleeve resection with right upper lobectomy for 
carcinoma in 1952 by Allison [36–38].
Today, anatomic pulmonary resection remains the best curative option in 
patients with early-stage lung cancer. The first VATS lobectomy series was reported 
in 1992 by Lewis [39].
In the following years, different surgeons defined unique techniques and pio-
neered the development of VATS however, the variability in the technique and the 
skeptical approach to published results prevented VATS from being widely accepted 
until the 2000s [40–42].
In addition to being technically feasible, superior postoperative results com-
pared to thoracotomy have been effective in the general acceptance of VATS 
(Figure 5).
Long et al. conducted a prospective randomized trial comparing the quality 
of life after VATS vs. open lobectomy for clinically early-stage NSCLC [42]. It was 
stated that a month after operation both dyspnea and pain score were significantly 
lower in the VATS group.
In another study, Andretti et al. documented the results of 145 patients and 
compared the postoperative pain of patients who underwent VATS and mini thora-
cotomy. It was stated that significantly less pain was observed in the VATS group at 
the 1st, 12th, 24th and 48th postoperative hours [43].
The advantages of VATS over thoracotomy have also been revealed in other stud-
ies conducted with large patient groups:
McKenna Jr. et al. published experiences of 1,100 cases and reported 0.8% 
mortality and 15.3% morbidity [4].
In another study, Boffa et al. analyzed data of 9033 pulmonary resections for 
primary lung cancer by using the database of the Society of Thoracic Surgeons. 
In this study, VATS resection was performed in 2429 of 9033 patients. In the VATS 
group, the mortality rate was 2% and the overall morbidity was 32% [44].
Figure 5. 
The paratracheal lymph node, which could not be diagnosed by EBUS, was totally excised with VATS (VCS: 
Superior vena cava, T: Trachea, asterisk indicates paratracheal lymph node).
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Laursen et al. analyzed the results of 1379 patients who underwent lobectomy. 
In this study minor and major complications were found significantly lower in the 
VATS group [45].
Compared to the mortality (%1–2) and morbidity (%32–37) of open lobecto-
mies from large series in the literature, the results are highly satisfactory [46].
The risk of compromising the oncological principles in VATS has been a matter 
of debate for a long time. However, in the retrospective large-scale studies, no sig-
nificant difference was found between VATS and thoracotomy in terms of oncologi-
cal results. Watanabe et al. reported no differences in the total number of lymph 
nodes, nodal stations, mediastinal nodes, and stations sampled during systematic 
lymph node dissection between VATS and thoracotomy groups [47].
Moreover, Yang et al. reported the long-term results of VATS and open lobec-
tomy based on the National Cancer Data Base of the U.S. About three thousand 
patients with stage I NSCLC was matched with propensity score from >7,000 
patients; the 5-year OS rates of the two groups were similar [48].
Figure 6. 
A case of right upper lobectomy performed using the anterior approach. In the hilum, the upper lobe vein, 
artery and bronchus were dissected and divided sequentially from anterior to posterior. a. the asterisk indicates 
the vein of the right upper lobe and triangle indicates the middle lobe vein. b. the arrow indicates pulmonary 
vein stump. The asterisk and triangle indicate pulmonary arterial branches. c. after the dissection of the 
arterial branch of the right upper lobe, upper lobe bronchus was seen (asterisk). d. after dividing the vascular 
and bronchial structures belonging to the upper lobe, the interlobar fissure is finally divided with the help of 
endoscopic stapler.
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Nowadays, the indications of VATS have expanded with the increasing experi-
ence. It can be successfully applied in cases with neoadjuvant therapy, tumor larger 
than 5 cm, chest wall invasion, need of sleeve resection, which was previously 
considered as a relative or absolute contraindication.
Park BJ et al. analyzed 428 patients who underwent induction chemotherapy for 
lung cancer and compared thoracotomy and minimally invasive surgical approaches 
in this patient group. There were not seen any differences in disease-free and overall 
survival between minimally invasive surgery and thoracotomy groups [49].
Huang et al. presented the results of 118 patients who underwent VATS bron-
chial sleeve lobectomy and postoperative complications were reported in only 2 
patients.
In a study, we conducted in our clinic, which included 60 patients with tumors 
larger than 5 cm, mean drainage time and postoperative length of hospital stay were 
significantly shorter [50] (Figure 6).
5. Contraindications for VATS anatomic lung resection
With the widespread use of the VATS technique, many contraindications related 
to the procedure have been described [51]. However, these contraindications have 
changed over time, thanks to the increasing experience in VATS and the need-
oriented developments and diversity of thoracoscopic instruments.
Many conditions such as the presence of endobronchial lesions, history of 
neoadjuvant treatment, pleural adhesions, and tumor larger than 3 cm, which were 
previously contraindicated for VATS, are not considered as contraindications by 
many surgeons today.
Sleeve resections with VATS can be successfully applied in patients with endo-
bronchial lesions.
Moreover, many studies have demonstrated that VATS can be applied with low 
complication rates after neoadjuvant therapy or in cases with large tumors [49–52].
Large mediastinal vessel, pericardium, carina, and chest wall invasions can be 
considered relatively contraindicated for VATS. These kinds of major resections 
must be performed in high-volume institutions and by experienced surgeons.
6. Learning curve for VATS
Mc Kenna has been suggested that the length of the VATS lobectomy learning curve 
should consist of 50 lobectomies however, there are several personal and environmen-
tal factors that affect the learning curve associated with VATS lobectomy [53]. If we 
put aside personal factors such as instrument use, anatomy mastery and 3-dimensional 
thinking ability, there are 2 main factors affecting the learning curve: The size of the 
center and the presence of experienced surgeons who can supervise [51, 53, 54].
The prolongation of the time between the two cases will adversely affect the 
learning process. In centers where there are not many cases, this deficiency can be 
partially eliminated with VATS videos or simulators.
7. Conclusions
Minimally invasive thoracic surgery has made great progress in the past 20 years 
and today it has an important role in both diagnosis and treatment of lung cancer. 
However, VATS lobectomy is a relatively young technique and is still evolving.
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